Lexaria Bioscience (LLX.C) announced today that treatment and dosing in its human clinical study, HYPER-H21-1, have been completed ahead of schedule. Read full article here: https://equity.guru/2021/06/07/lexaria-bioscience-lxx-c-releases-progress-report-for-first-human-clinical-study/…
Search Results for: lxx.c
Lexaria Bioscience (LLX.C) announced today that treatment and dosing in its human clinical study, HYPER-H21-1, have been completed ahead of schedule. “Completing this work in the midst of…
Lexaria Bioscience (LXX.C) has received test results for two new DehydraTECH 2.0 cannabidiol (CBD) formulations in its second 2021 applied research and development study program, HYPER-A21-2. Read full article…
Lexaria Bioscience (LXX.C) has received test results for two new DehydraTECH 2.0 cannabidiol (CBD) formulations in its second 2021 applied research and development study program, HYPER-A21-2. “One of our…
Lexaria Bioscience (LXX.C) has provided positive results from its extended stability testing, which has reported unparalleled stability for bottled cannabidiol (CBD)-containing beverages prepared using its technology. “I love reminding…
Earlier this week, a subsidiary of Lexaria Bioscience (LXX.C) received a R&D license from Health Canada, prompting the question, ‘we have those?’ “You were as surprised as we were,” said…
@presley1000 @ChrisParry nahh he’ll probably take some of the credit lol — dielawn (@Dyro01676) January 9, 2017 There’s an old way of thinking in the marketing game that, if…
Continuing our series of interviews with people we’ve kicked about in 2016, one company that I’ve often lambasted is Lexaria Biosciences (LXX.V). Why have I given them crap? Because…
Tobacco giant, Altria Group (MO.NYSE), is lobbying in the United States for “matters pertaining to hemp and crop insurance,” among other things, seemingly aiming to pivot away from vaping…
Everyone remembers last autumn’s spectacular surge in the Canadian-listed cannabis stocks, particularly the ones that have US operations. Tinley Beverage Co. (TNY.C) went from $0.04 to $0.68, Nutritional High…